Tempus Is Eric Lefkofsky’s Latest Philanthropic Project And Company

The medical industry is always improving and finding new ways to help people with their problems. Out of all the medical problems people can find themselves dealing with cancer is typically one of the worst ones. This is not only because of what it does to the body and how painful it can be, but because there is no specific cure. Eric Lefkofsky is a businessman and entrepreneur that has found success in various different companies today, including Tempus, which is focused on compiling data related to cancer from all over the world. Despite the ever-advancing industry, Eric saw up close that the medical field was lacking in terms of technology when it came to their ability to sort and structure data.

Eric Lefkofsky co-founded Tempus with a longtime friend, Brad Keywell, and the company currently resides in Chicago. As the CEO of Tempus, Eric Lefkofsky has big plans for the company and its research. Eric has personally invested millions into this company to ensure its success. By compiling molecular and genomic data from patient files around the world, Tempus will be able to provide doctors with all the information and notes they could need to personalize their treatment for each cancer patient. While this does not specifically fight cancer, it allows medical practitioners to fight it to the best of their ability for everyone that is afflicted.

Tempus is a new idea for Eric Lefkofsky, but his generosity and desire to help others has been a longtime commitment for him. Eric and his wife founded and run their own charitable foundation that works to help gives students a better education all over the country. Various programs at Eric’s foundation help students get into all sorts of industries today, including medical, art, history, and even human rights. At the end of the day, almost everything Eric works to achieve is also work towards helping others and creating a better global community.

Read More: www.crunchbase.com/person/eric-lefkofsky

Dr. Mark Holterman Continues To Move Forward

At the same time as Dr. Mark Holterman carries out his responsibilities as an active pediatric surgeon, college professor and researcher, he also achieves many philanthropic initiatives.


Dr. Holterman, who has worked for more than two decades as a pediatric surgeon and a professor of surgery educates students at the University of Illinois, College of Medicine. In addition, he founded Mariam Global Health, which funds and manages inventive medical businesses.


He is actively involved in global medical activities such as the International Pediatric Specialists Alliance for the Children of Vietnam (IPSAC-VN) which works with medical schools and hospitals to improve health care for the children in Vietnam.


IPSAC-VN, which is headquartered in Vietnam, works through educating and training programs, academic support and providing outreach surgery to remote areas with the help of volunteer practitioners and support personnel. The group is also working to make new equipment available to Vietnamese medical facilities.


Volunteers, who are urgently needed to provide patient care, and who are interested in working with the IPSAC-VN, can travel to Vietnam as long as they have a copy of their medical license and a valid passport that stays legally binding for a minimum of six months after the scheduled stay (GazetteDay).


Volunteers at IPSAC-VN plan to launch a Vietnam mission in 2018 to Ho Chi Minh City.


Another charity that provides medical and surgical services worldwide, a non-profit volunteer group, the Children’s Surgery International (CSI), helps underprivileged children and families around the world.


Among the most common surgeries completed on children are organ transplants, tumor removal, brain surgery and corrective surgeries.


Dr. Holterman graduated from Yale University and went on to earn his MD and Ph.D. from the University of Virginia. He has authored many scientific papers and medical texts.


For his efforts in fighting diabetes, the American Diabetes Association presented Dr. Holterman with its Innovative Research Award.


The original story can be found at http://medicaldailytimes.com/medicine/dr-mark-holterman/2946/.